A federal bill called the Combat Meth Act of 2005, an attempt to respond
to the illegal production, distribution, and use of methamphetamine in the
United States, is wending its way through Congress. The bill, modeled after
an Oklahoma law passed last year, requires pharmacists to oversee the sale
and prevent the purchase of large quantities of certain cold medications containing
pseudoephedrine. That law has been found to be an effective deterrent to the
illegal production of methamphetamine, which can be manufactured from ingredients
that include pseudoephedrine.
Hampton T. Methamphetamine Abuse. JAMA. 2005;293(18):2204. doi:10.1001/jama.293.18.2204-a
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: